Protalix Biotherapeutics Inc (NYSE:PLX) stock is riding a nearly 10% gain this morning after the Israeli biotech firm …
PLx Pharma Inc. (NASDAQ: PLXP) is going to be rather risky due to its market value of just $63 million. Last seen at $7.20, the shares have a 52-week range of $5.60 to $12.80, and the stock is classified as low volume by traders. PLx …
To use net proceeds from this offering, together with current cash resources, to advance aspertec 325 mg to market-readiness * Pricing of registered direct offering of 2.65 million shares of common stock at an offering price per share of …
The article published is based on studies that examined the effect of PLX cells that had been induced with tumor ... The …
Investors in Protalix BioTherapeutics, Inc. PLX need to pay close attention to the stock based on moves in the options market lately. That is because the November 11 th, 2017 $2 Call had some of the highest implied volatility of all equity …
Protalix BioTherapeutics, Inc PLX was a big mover last session, as the company saw its shares rise 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which …